BISC Global

Ghent, Belgium Founded: 2017 • Age: 9 yrs Acquired By Excelra
Bioinformatics and biostatistics services are provided to life science firms.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees 15 Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors 11 Brand Intelligence

About BISC Global

BISC Global is a company based in Ghent (Belgium) founded in 2017 was acquired by Excelra in April 2023. The company has 15 employees as of June 30, 2022. BISC Global operates in a competitive market with competitors including Rejuvenate Bio, Novogene Corporation, Clinical Microbiomics, BGI and Genewiz, among others.

  • Headquarter Ghent, Belgium
  • Employees 15 as on 30 Jun, 2022
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Legal Name Bisc Global
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
    $494.37 K (USD)
    474
    as on Jun 30, 2022
  • EBITDA
    $781.77 K (USD)
    357
    as on Jun 30, 2022
  • Latest Funding Round
  • Investors
  • Employee Count
    15

    as on Jun 30, 2022

  • Acquired by
    Excelra

    (Apr 19, 2023)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

People of BISC Global

Headcount 10-50
Employee Profiles 7
Employee Profiles
People
Maarten Braspenning
Founder & CEO
People
Ngoc Pham
Senior Consultant, Machine Learning, Bioinformatics
People
Stephani Lane
Senior US HR Business Partner
People
Siebe Vandecasteele
Business Development Manager

Unlock access to complete

Funding Insights of BISC Global

Investors in BISC Global

BISC Global has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Excelra.

All
Institutional
Investor Description Founded Year Domain Location
Bioinformatics platform developed for in silico analysis of drug candidates.
Founded Year Domain Location

Investments & Acquisitions by BISC Global

Investments

Financial Statements - BISC Global

Bisc Global Comparisons

+
Add Comparison
Available on Premium

Competitors of BISC Global

BISC Global operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Rejuvenate Bio, Novogene Corporation, Clinical Microbiomics, BGI and Genewiz, among others.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Gene-editing platform and anti-aging therapy for dogs are developed.
domain founded_year HQ Location
Genomic services and solutions with NGS expertise are provided.
domain founded_year HQ Location
Meta-genomics platforms and services for microbiome studies are provided.
domain founded_year HQ Location
BGI is engaged in genomics and precision medicine solutions.
domain founded_year HQ Location
Genomic services are provided for the life sciences industry.
domain founded_year HQ Location
NGS-based diagnostic solutions for neonatal screening are developed.

Latest news on Bisc Global

Frequently Asked Questions about BISC Global

BISC Global was founded in 2017.

BISC Global is headquartered in Ghent, Belgium. It is registered at Ghent, East Flanders, Belgium.

Anandbir Singh Brar is the current CEO of BISC Global.

As of Jun 30, 2022, the latest employee count at BISC Global is 15.

BISC Global was established in 2017 in Ghent, Belgium, as a provider of bioinformatics and biostatistics services. Support is offered to life science companies through data analysis, statistical modeling, and computational tools for research applications. Operations are centered in the European life sciences sector, with services addressing needs in pharmaceuticals and biotechnology. Leadership is held by CEO Anandbir Singh Brar, overseeing delivery to clients in the region.

BISC Global's top competitors include Novogene Corporation, BGI and Source BioScience.

BISC Global has 1 investor. Key investors include Excelra.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available